Cikaric 2005.
Methods | RCT 2002‐2003 |
|
Participants | 200 patients Stage IIB to IVA |
|
Interventions | Radiotherapy versus concomitant chemoradiotherapy (Cisplatin) | |
Outcomes | Survival, disease‐free survival, local and distant recurrence, acute toxicity, late toxicity | |
Notes | ||
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk | Data checks on IPD provided suggest adequate sequence generation |
Allocation concealment (selection bias) | Low risk | Sealed envelope |
Blinding (performance bias and detection bias) All outcomes | High risk | Trial was not blinded due to nature of treatment interventions |
Incomplete outcome data (attrition bias) All outcomes | Low risk | IPD provided for all outcomes |
Selective reporting (reporting bias) | Low risk | N/A (IPD supplied for all outcomes) |
Other bias | Low risk | Data checks on IPD provided suggest study is free of follow‐up bias |